SIEMENS HEALTHINEERS ENTERS INTO LICENSE AND SUPPLY ARRANGEMENT WITH QUANTERIX FOR ACCESS TO NEUROFILAMENT LIGHT (NF-L) ANTIBODIES TO DEVELOP NF-L ASSAYS

NOVEMBER 04, 2019 BILLERICA, Mass.–(BUSINESS WIRE)–Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced it has entered into a licensing and supply arrangement with Siemens Healthineers for access to Quanterix’ proprietary Nf-L antibodies, which were recently acquired from UmanDiagnostics. Access to the Nf-L antibodies will allow Siemens... Read more

Coming Soon to the Siemens Healthineers Aptio Automation System: iSpecimen Integrated Solution

— Scientists require human biofluid, tissue and cell specimens that meet precise requirements to advance biomedical research, but often have difficulty locating the specific patient samples they need. — iSpecimen works with laboratories to compliantly aggregate for researchers remnant human samples that would otherwise be discarded. — Using the CentraLink Data Management System and Aptio... Read more